Development of a Probiotic Strategy to Prevent or Eliminate Nasal Colonization With S. Aureus

Hemodialysis Clinical Trial

Official title:

Development of a Probiotic Strategy to Prevent or Eliminate Nasal Colonization With S Aureus

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT00977496
• Other study ID #: 8784
• Status: Withdrawn
• Phase: N/A
• First received: September 14, 2009
• Last updated: March 17, 2015
• Start date: May 2011

Study information

• Verified date: March 2015
• Source: Tufts Medical Center
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

The goal of this study is characterize the changes in bacterial diversity of the nares of hemodialysis patients. Another goal is to determine when hemodialysis patients become colonized with the bacteria Staphylococcus aureus, as nasal colonization with S. aureus is a major risk factor for invasive infection in hemodialysis patients. Fifteen subjects will be recruited into the study. Nasal swabs will be collected every month for six months or until one month after S. aureus colonization in order to determine any changes in the bacterial communities of the nose. Clinical data will also be collected to evaluate the possible influence of external factors on changes in the microbial communities in the patients' noses. This study will provide preliminary data on whether oral- and/or nasal-administered probiotics can eliminate nasal carriage of S. aureus.

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Male and female subjects aged 18 years or older

• On a stable hemodialysis schedule three times a week at Tufts Medical Center outpatient hemodialysis unit

• Able to speak English, Spanish, Cantonese, or Mandarin (One of these languages is spoken by >95% of our hemodialysis population)

• Provides informed consent to participate in the study

• No plans to be absent from the dialysis unit in the next 6 months

• Willingness to report on adverse events during the study period

Exclusion Criteria:

• Patients in which hemodialysis was indicated for acute renal failure secondary to septic shock, acute tubular necrosis, or other condition which is felt to be temporary or secondary to a life threatening illness or likelihood of hemodialysis for less than 6 months.

• Treatment with systemic anti-staphylococcal antibiotic therapy within 30 days prior to enrollment or planned use of topical mupirocin applied to the nares

• Receiving peritoneal dialysis (concordance between the colonizing and infecting strain is not as high as in the hemodialysis population (105))

• Absolute neutrophil count less than 500/mm3 or anticipated fall in neutrophil count < 500/mm3 (e.g. as a result of recent chemotherapy)

• Bleeding diathesis such as platelets count less than 20 or INR >4 within the last 30 days

• On immunosuppressive therapy

• Anticipated renal transplant during the next 6 months

• Evidence of active bowel leak, acute abdomen or colitis

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Hemodialysis

Intervention

Procedure:
• Nasal Swab
Swabs will be moistened in sterile 0.9% sodium chloride solution and rotated in the anterior vestibule of both nares and processed for S aureus cultures and for bacterial DNA extraction.

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Tufts Medical Center

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	To describe the clinical variables that may be associated with the acquisition of S aureus nasal colonization, over a six-month period.		Monthly for 6 months or monthly until 1 month after positive nasal swab for S aureus	No
Primary	To refine and test the feasibility of using non culture-based methods to study the microbial ecology and bacterial diversity of the anterior nares in patients starting hemodialysis using 16sRNA sequence analysis.		Monthly for 6 months or monthly until 1 month after positive nasal swab for S aureus	No
Primary	To explore changes in bacterial diversity in the anterior nares over a six-month period and in conjunction with S aureus colonization.		Monthly for 6 months or monthly until 1 month after positive nasal swab for S aureus	No